Tus khub:

Yam khoom muaj nqis:

Partner Background:

Partnership Paub meej:

Tus khub:

Yam khoom muaj nqis:

Immuno-Oncology

Partner Background:

Yuhan Corporation yog ib lub tuam txhab tshuaj Korean loj tshaj plaws, nrhiav tau tshaj 80 xyoo dhau los

Partnership Paub meej:

Koom tes koom tes hu ua ImmuneOncia Therapeutics, LLC

Tsom ntsoov rau kev txhim kho thiab ua lag luam ntau ntawm cov tshuaj tiv thaiv kab mob tiv thaiv kab mob rau hematological malignancies thiab cov qog nqaij hlav.

Tus khub:

Yam khoom muaj nqis:

Immuno-Oncology

Partner Background:

Lee's Pharm yog lub tuam txhab biopharma pej xeem nrog ntau tshaj 20 xyoo ntawm kev ua haujlwm hauv Suav teb thiab tam sim no ua lag luam 14 cov khoom hauv PRC

Partnership Paub meej:

Sorrento tau tso cai tshwj xeeb rau Lee's Pharm los tsim thiab ua lag luam tag nrho tib neeg los tiv thaiv PD-L1 mAb STI-A1014 rau kev lag luam Suav ntau dua

Tus khub:

Yam khoom muaj nqis:

Kev Kho Mob Cell

Partner Background:

Celularity yog ib qho spin-off los ntawm Celgene Corporation tsom mus rau cov placenta-derived thiab cord-blood derived hlwb kho

Partnership Paub meej:

Equity Investment thiab Board Representation

Tus khub:

Yam khoom muaj nqis:

Immuno-oncology

Partner Background:

MAPHARM yog lub tuam txhab biopharma tsom rau R & D thiab tsim cov tshuaj tshiab thiab "Biobetters" rau mob qog noj ntshav thiab kab mob autoimmune.

Partnership Paub meej:

Sorrento muaj daim ntawv tso cai tshwj xeeb rau kev lag luam plaub Biobetters uas tau ua tiav Phase 3 kev tshawb fawb hauv Suav teb rau North American, European thiab Nyiv kev lag luam